Global Market Report

Global Recombinant Protein Drug Market Professional Research Report 2014-2026, Segmented by Players, Types, End-Users in Major 40 Countries or Regions

  • POSTDATE：Apr 01, 2019
  • PAGES：169
  • REPORT CODE：GMM195653
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • Driven by the downstream end-users, the market of Recombinant Protein Drug witnessed a growth from XX.00 Million USD in 2014 to XX.00 Million USD in 2018, with a CAGR of XX.00%. Moreover, the forecast of 2019-2026 Recombinant Protein Drug market is offered. The research provides insights for the global Recombinant Protein Drug market based on different Types, End-Users and Regions, and competitive landscape of these segments are analyzed in detail.


    A wide range of market influence factors are taken into consideration in the analysis, and potential developing factors for different Types, End-Users and Regions are also included in the report in order to figure out the most promising development trends in the Recombinant Protein Drug industry. For presenting the most potential investment fields in North America, Europe, Asia Pacific and Latin America, Middle East & Africa, the market capacity and consumption potential of more than 34 major powers are covered in the research, providing valuable opinions of strategic adjustments for existing groups and new entrants.


    The Snapshot of Global Recombinant Protein Drug Market Segmentations:

    By Players:

    • NCPC

    • Pharmingen

    • Merck Serono

    • GenSci

    • Kyowa Hakko Kirin

    • Anhui Anke Biotechnology

    • Novo Nordisk

    • Sanofi

    • Abcam

    • Eli Lilly

    • SL PHARM

    • Changchun High & New Technology Industry

    • Amgen

    • Heng Rui

    • Ortho Biotech

    • Shenzhen Neptunus Interlong Bio-Technique

    • Livzon Pharm

    • Roche


    By Types:

    • Recombinant Insulin

    • Recombinant Human Interferon (rhIFN)

    • Recombinant Human Erythropoietin (rhEPO)

    • Recombinant Human Granulocyte Colony-stimulating Factor (rhG-CSF)

    • Recombinant Human Growth Hormone (rhGH)

    • Recombinant Human Follicle-stimulating Hormone (rh


    By End-User:

    • Hospital use

    • Clinic use

    • Household


    By Regions:

    North America

    • United States

    • Canada

    • Mexico


    Europe

    • Germany

    • UK

    • France

    • Italy

    • Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden)

    • Spain

    • Belgium

    • Poland

    • Russia

    • Turkey

    • Others


    Asia-Pacific

    • China

    • Japan

    • India

    • South Korea

    • Australia and New Zealand

    • ASEAN Countries (Indonesia, Thailand, Malaysia, Singapore, Philippines, Vietnam, Others)


    Latin America, Middle East & Africa

    • GCC Countries (Saudi Arabia, United Arab Emirates, Qatar, Others)

    • Brazil

    • Nigeria

    • South Africa

    • Argentina

    • Others


    Reasons to Purchase the Recombinant Protein Drug Market Report

    • Vertical Market Divisions by Type and End-Users

    • The Most Promising Regions in the Forecast Period

    • Competitive Landscape

    • Key Players’ Strategies and Their Product Offerings

    • Recombinant Protein Drug Market Current Trends/Restraints/Challenges/Opportunities

    • Potential and Niche Market / Regions with Promising Growth

    • Objective Analysis Towards Market Performance

  • Table of Contents

    1 Report Overview

    • 1.1 Product Definition and Scope

    • 1.2 PEST (Political, Economic, Social and Technological) Analysis of Recombinant Protein Drug Market

    • 1.3 Market Segmentation by Type

      • 1.3.1 Global Recombinant Protein Drug Market Share by Types

      • 1.3.2 Global Recombinant Protein Drug Market Size and Growth Rate of Recombinant Insulin from 2014 to 2026

      • 1.3.3 Global Recombinant Protein Drug Market Size and Growth Rate of Recombinant Human Interferon (rhIFN) from 2014 to 2026

      • 1.3.4 Global Recombinant Protein Drug Market Size and Growth Rate of Recombinant Human Erythropoietin (rhEPO) from 2014 to 2026

      • 1.3.5 Global Recombinant Protein Drug Market Size and Growth Rate of Recombinant Human Granulocyte Colony-stimulating Factor (rhG-CSF) from 2014 to 2026

      • 1.3.6 Global Recombinant Protein Drug Market Size and Growth Rate of Recombinant Human Growth Hormone (rhGH) from 2014 to 2026

      • 1.3.7 Global Recombinant Protein Drug Market Size and Growth Rate of Recombinant Human Follicle-stimulating Hormone (rh from 2014 to 2026

    • 1.4 Market Segmentation by End-Users

      • 1.4.1 Global Recombinant Protein Drug Market Share by End-Users

      • 1.4.2 Global Recombinant Protein Drug Market Size and Growth Rate of Hospital use from 2014 to 2026

      • 1.4.3 Global Recombinant Protein Drug Market Size and Growth Rate of Clinic use from 2014 to 2026

      • 1.4.4 Global Recombinant Protein Drug Market Size and Growth Rate of Household from 2014 to 2026

    • 1.5 Market Segmentation by Regions

      • 1.5.1 North America Recombinant Protein Drug Consumption Market Size and Growth Rate from 2014 to 2026

        • 1.5.1.1 United States Recombinant Protein Drug Consumption Market Size and Growth Rate from 2014 to 2026

        • 1.5.1.2 Canada Recombinant Protein Drug Consumption Market Size and Growth Rate from 2014 to 2026

        • 1.5.1.3 Mexico Recombinant Protein Drug Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.2 Europe Recombinant Protein Drug Consumption Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.1 Germany Recombinant Protein Drug Consumption Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.2 UK Recombinant Protein Drug Consumption Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.3 France Recombinant Protein Drug Consumption Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.4 Italy Recombinant Protein Drug Consumption Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.5 Nordic Countries Recombinant Protein Drug Consumption Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.6 Spain Recombinant Protein Drug Consumption Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.7 BelgiumRecombinant Protein Drug Consumption Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.8 Poland Recombinant Protein Drug Consumption Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.9 Russia Recombinant Protein Drug Consumption Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.10 Turkey Recombinant Protein Drug Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.3 Asia-Pacific Recombinant Protein Drug Consumption Market Size and Growth Rate from 2014 to 2026

        • 1.5.3.1 China Recombinant Protein Drug Consumption Market Size and Growth Rate from 2014 to 2026

        • 1.5.3.2 Japan Recombinant Protein Drug Consumption Market Size and Growth Rate from 2014 to 2026

        • 1.5.3.3 Australia and New Zealand Recombinant Protein Drug Consumption Market Size and Growth Rate from 2014 to 2026

        • 1.5.3.4 India Recombinant Protein Drug Consumption Market Size and Growth Rate from 2014 to 2026

        • 1.5.3.5 ASEAN Countries Recombinant Protein Drug Consumption Market Size and Growth Rate from 2014 to 2026

        • 1.5.3.6 South Korea Recombinant Protein Drug Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.4 Latin America, Middle East & Africa Recombinant Protein Drug Consumption Market Size and Growth Rate from 2014 to 2026

        • 1.5.4.1 GCC Countries Recombinant Protein Drug Consumption Market Size and Growth Rate from 2014 to 2026

        • 1.5.4.2 Brazil Recombinant Protein Drug Consumption Market Size and Growth Rate from 2014 to 2026

        • 1.5.4.3 Nigeria Recombinant Protein Drug Consumption Market Size and Growth Rate from 2014 to 2026

        • 1.5.4.4 South Africa Recombinant Protein Drug Consumption Market Size and Growth Rate from 2014 to 2026

        • 1.5.4.5 Argentina Recombinant Protein Drug Consumption Market Size and Growth Rate from 2014 to 2026


    2 Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Market Challenges and Restraints 

      • 2.1.2 Market Opportunities and Potentials

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape Analysis

      • 2.2.1 Industrial Concentration Analysis

      • 2.2.2 Porter's Five Forces Analysis of the Industry

      • 2.2.3 SWOT Analysis for New Entrants


    3 Segmentation of Recombinant Protein Drug Market by Types

    • 3.1 Product Development Trends of Different Types

    • 3.2 Commercial Product Types of Major Vendors

    • 3.3 Competitive Landscape Analysis of Different Types

    • 3.4 Market Size of Recombinant Protein Drug by Major Types

      • 3.4.1 Market Size and Growth Rate of Recombinant Insulin

      • 3.4.2 Market Size and Growth Rate of Recombinant Human Interferon (rhIFN)

      • 3.4.3 Market Size and Growth Rate of Recombinant Human Erythropoietin (rhEPO)

      • 3.4.4 Market Size and Growth Rate of Recombinant Human Granulocyte Colony-stimulating Factor (rhG-CSF)

      • 3.4.5 Market Size and Growth Rate of Recombinant Human Growth Hormone (rhGH)

      • 3.4.6 Market Size and Growth Rate of Recombinant Human Follicle-stimulating Hormone (rh


    4 Segmentation of Recombinant Protein Drug Market by End-Users

    • 4.1 Downstream Client Analysis by End-Users

    • 4.2 Competitive Landscape Analysis of Different End-Users

    • 4.3 Market Potential Analysis of Different End-Users

    • 4.4 Market Size of Recombinant Protein Drug by Major End-Users

      • 4.4.1 Market Size and Growth Rate of Recombinant Protein Drug for Hospital use

      • 4.4.2 Market Size and Growth Rate of Recombinant Protein Drug for Clinic use

      • 4.4.3 Market Size and Growth Rate of Recombinant Protein Drug for Household


    5 Market Analysis by Major Regions

    • 5.1 Global Recombinant Protein Drug Production Analysis by Major Regions

    • 5.2 Global Recombinant Protein Drug Consumption Analysis by Major Regions

    • 5.3 Global Recombinant Protein Drug Production, Import, Consumption and Export Analysis by Regions

      • 5.3.1 North America Recombinant Protein Drug Production, Import, Consumption and Export Analysis 

      • 5.3.2 Europe Recombinant Protein Drug Production, Import, Consumption and Export Analysis

      • 5.3.3 Asia Pacific Recombinant Protein Drug Production, Import, Consumption and Export Analysis

      • 5.3.4 Latin America, Middle East & Africa Recombinant Protein Drug Production, Import, Consumption and Export Analysis


    6 Product Commodity of Recombinant Protein Drug Market in Major Countries

    • 6.1 Top 5 Export Countries in Recombinant Protein Drug market from 2014 to 2019

      • 6.1.1 Top 5 Export Countries' Export Value Analysis in Recombinant Protein Drug market from 2014 to 2019

      • 6.1.2 Top 5 Export Countries'  Export Volume Analysis in Recombinant Protein Drug market from 2014 to 2019

    • 6.2 Top 5 Import Countries in Recombinant Protein Drug market from 2014 to 2019

      • 6.2.1 Top 5 Import Countries' Import Value Analysis in Recombinant Protein Drug market from 2014 to 2019

      • 6.2.2 Top 5 Import Countries' Import Volume Analysis in Recombinant Protein Drug market from 2014 to 2019

    • 6.3 Emerging Top 3 Export Countries Analysis

    • 6.4 Emerging Top 3 Import Countries Analysis


    7 North America Recombinant Protein Drug Landscape Analysis

    • 7.1 North America Recombinant Protein Drug Landscape Analysis by Major Types

    • 7.2 North America Recombinant Protein Drug Landscape Analysis by Major End-Users

    • 7.3 North America Recombinant Protein Drug Landscape Analysis by Major Countries

      • 7.3.1 United States Recombinant Protein Drug Market Volume and Growth Rate

      • 7.3.2 Canada Recombinant Protein Drug Market Volume and Growth Rate

      • 7.3.3 Mexico Recombinant Protein Drug Market Volume and Growth Rate


    8 Europe Recombinant Protein Drug Landscape Analysis

    • 8.1 Europe Recombinant Protein Drug Landscape Analysis by Major Types

    • 8.2 Europe Recombinant Protein Drug Landscape Analysis by Major End-Users

    • 8.3 Europe Recombinant Protein Drug Landscape Analysis by Major Countries

      • 8.3.1 Germany Recombinant Protein Drug Market Volume and Growth Rate

      • 8.3.2 UK Recombinant Protein Drug Market Volume and Growth Rate

      • 8.3.3 France Recombinant Protein Drug Market Volume and Growth Rate

      • 8.3.4 Italy Recombinant Protein Drug Market Volume and Growth Rate

      • 8.3.5 Nordic Countries Recombinant Protein Drug Market Volume and Growth Rate

      • 8.3.6 Spain Recombinant Protein Drug Market Volume and Growth Rate

      • 8.3.7 Belgium Recombinant Protein Drug Market Volume and Growth Rate

      • 8.3.8 Poland Recombinant Protein Drug Market Volume and Growth Rate

      • 8.3.9 Russia Recombinant Protein Drug Market Volume and Growth Rate

      • 8.3.10 Turkey Recombinant Protein Drug Market Volume and Growth Rate


    9 Asia Pacific Recombinant Protein Drug Landscape Analysis

    • 9.1 Asia Pacific Recombinant Protein Drug Landscape Analysis by Major Types

    • 9.2 Asia Pacific Recombinant Protein Drug Landscape Analysis by Major End-Users

    • 9.3 Asia Pacific Recombinant Protein Drug Landscape Analysis by Major Countries

      • 9.3.1 China Recombinant Protein Drug Market Volume and Growth Rate

      • 9.3.2 Japan Recombinant Protein Drug Market Volume and Growth Rate

      • 9.3.3 Australia and New Zealand Recombinant Protein Drug Market Volume and Growth Rate

      • 9.3.4 India Recombinant Protein Drug Market Volume and Growth Rate

      • 9.3.5 ASEAN Countries Recombinant Protein Drug Market Volume and Growth Rate

      • 9.3.6 South Korea Recombinant Protein Drug Market Volume and Growth Rate


    10 Latin America, Middle East & Africa Recombinant Protein Drug Landscape Analysis

    • 10.1 Latin America, Middle East & Africa Recombinant Protein Drug Landscape Analysis by Major Types

    • 10.2 Latin America, Middle East & Africa Recombinant Protein Drug Landscape Analysis by Major End-Users

    • 10.3 Latin America, Middle East & Africa Recombinant Protein Drug Landscape Analysis by Major Countries

      • 10.3.1 GCC Countries Recombinant Protein Drug Market Volume and Growth Rate

      • 10.3.2 Brazil Recombinant Protein Drug Market Volume and Growth Rate

      • 10.3.3 Nigeria Recombinant Protein Drug Market Volume and Growth Rate

      • 10.3.4 South Africa Recombinant Protein Drug Market Volume and Growth Rate 

      • 10.3.5 Argentina Recombinant Protein Drug Market Volume and Growth Rate

       

    11 Major Players Profile

    • 11.1 NCPC

      • 11.1.1 NCPC Company Profile and Development Status

      • 11.1.2 Market Performance

      • 11.1.3 Product and Service Introduction

    • 11.2 Pharmingen

      • 11.2.1 Pharmingen Company Profile and Development Status

      • 11.2.2 Market Performance

      • 11.2.3 Product and Service Introduction

    • 11.3 Merck Serono

      • 11.3.1 Merck Serono Company Profile and Development Status

      • 11.3.2 Market Performance

      • 11.3.3 Product and Service Introduction

    • 11.4 GenSci

      • 11.4.1 GenSci Company Profile and Development Status

      • 11.4.2 Market Performance

      • 11.4.3 Product and Service Introduction

    • 11.5 Kyowa Hakko Kirin

      • 11.5.1 Kyowa Hakko Kirin Company Profile and Development Status

      • 11.5.2 Market Performance

      • 11.5.3 Product and Service Introduction

    • 11.6 Anhui Anke Biotechnology

      • 11.6.1 Anhui Anke Biotechnology Company Profile and Development Status

      • 11.6.2 Market Performance

      • 11.6.3 Product and Service Introduction

    • 11.7 Novo Nordisk

      • 11.7.1 Novo Nordisk Company Profile and Development Status

      • 11.7.2 Market Performance

      • 11.7.3 Product and Service Introduction

    • 11.8 Sanofi

      • 11.8.1 Sanofi Company Profile and Development Status

      • 11.8.2 Market Performance

      • 11.8.3 Product and Service Introduction

    • 11.9 Abcam

      • 11.9.1 Abcam Company Profile and Development Status

      • 11.9.2 Market Performance

      • 11.9.3 Product and Service Introduction

    • 11.10 Eli Lilly

      • 11.10.1 Eli Lilly Company Profile and Development Status

      • 11.10.2 Market Performance

      • 11.10.3 Product and Service Introduction

    • 11.11 SL PHARM

      • 11.11.1 SL PHARM Company Profile and Development Status

      • 11.11.2 Market Performance

      • 11.11.3 Product and Service Introduction

    • 11.12 Changchun High & New Technology Industry

      • 11.12.1 Changchun High & New Technology Industry Company Profile and Development Status

      • 11.12.2 Market Performance

      • 11.12.3 Product and Service Introduction

    • 11.13 Amgen

      • 11.13.1 Amgen Company Profile and Development Status

      • 11.13.2 Market Performance

      • 11.13.3 Product and Service Introduction

    • 11.14 Heng Rui

      • 11.14.1 Heng Rui Company Profile and Development Status

      • 11.14.2 Market Performance

      • 11.14.3 Product and Service Introduction

    • 11.15 Ortho Biotech

      • 11.15.1 Ortho Biotech Company Profile and Development Status

      • 11.15.2 Market Performance

      • 11.15.3 Product and Service Introduction

    • 11.16 Shenzhen Neptunus Interlong Bio-Technique

      • 11.16.1 Shenzhen Neptunus Interlong Bio-Technique Company Profile and Development Status

      • 11.16.2 Market Performance

      • 11.16.3 Product and Service Introduction

    • 11.17 Livzon Pharm

      • 11.17.1 Livzon Pharm Company Profile and Development Status

      • 11.17.2 Market Performance

      • 11.17.3 Product and Service Introduction

    • 11.18 Roche

      • 11.18.1 Roche Company Profile and Development Status

      • 11.18.2 Market Performance

      • 11.18.3 Product and Service Introduction


    12 Data Source and Research Methodology


    The List of Tables and Figures (Totals 99 Figures and 159 Tables)

    • Figure Product Picture

    • Figure Global Recombinant Protein Drug Market Size and Growth Rate of Recombinant Insulin from 2014 to 2026

    • Figure Global Recombinant Protein Drug Market Size and Growth Rate of Recombinant Human Interferon (rhIFN) from 2014 to 2026

    • Figure Global Recombinant Protein Drug Market Size and Growth Rate of Recombinant Human Erythropoietin (rhEPO) from 2014 to 2026

    • Figure Global Recombinant Protein Drug Market Size and Growth Rate of Recombinant Human Granulocyte Colony-stimulating Factor (rhG-CSF) from 2014 to 2026

    • Figure Global Recombinant Protein Drug Market Size and Growth Rate of Recombinant Human Growth Hormone (rhGH) from 2014 to 2026

    • Figure Global Recombinant Protein Drug Market Size and Growth Rate of Recombinant Human Follicle-stimulating Hormone (rh from 2014 to 2026

    • Figure Market Share by Type in 2014

    • Figure Market Share by Type in 2018

    • Figure Market Share by Type in 2026

    • Figure Global Recombinant Protein Drug Market Size and Growth Rate of Hospital use from 2014 to 2026

    • Figure Global Recombinant Protein Drug Market Size and Growth Rate of Clinic use from 2014 to 2026

    • Figure Global Recombinant Protein Drug Market Size and Growth Rate of Household from 2014 to 2026

    • Figure Market Share by End-User in 2014

    • Figure Market Share by End-User in 2018

    • Figure Market Share by End-User in 2026

    • Figure North America Recombinant Protein Drug Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure United States Recombinant Protein Drug Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Canada Recombinant Protein Drug Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Mexico Recombinant Protein Drug Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Europe Recombinant Protein Drug Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Germany Recombinant Protein Drug Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure UK Recombinant Protein Drug Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure France Recombinant Protein Drug Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Italy Recombinant Protein Drug Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Nordic Countries Recombinant Protein Drug Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Spain Recombinant Protein Drug Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Belgium Recombinant Protein Drug Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Poland Recombinant Protein Drug Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Russia Recombinant Protein Drug Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Turkey Recombinant Protein Drug Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Asia-Pacific Recombinant Protein Drug Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure China Recombinant Protein Drug Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Japan Recombinant Protein Drug Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Australia and New Zealand Recombinant Protein Drug Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure India Recombinant Protein Drug Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure ASEAN Countries Recombinant Protein Drug Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure South Korea Recombinant Protein Drug Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Latin America, Middle East & Africa Recombinant Protein Drug Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure GCC Countries Recombinant Protein Drug Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Brazil Recombinant Protein Drug Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Nigeria Recombinant Protein Drug Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure South Africa Recombinant Protein Drug Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Argentina Recombinant Protein Drug Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Development Trends and Industry Dynamics of Recombinant Protein Drug Industry

    • Figure Market Challenges and Restraints

    • Figure Market Opportunities and Potentials

    • Table Mergers and Acquisition

    • Figure Market Share of TOP 3 Players in 2018

    • Figure Market Share of TOP 5 Players in 2018

    • Figure Market Share of TOP 6 Players from 2014 to 2019

    • Figure Porter's Five Forces Analysis

    • Figure New Entrant SWOT Analysis

    • Table Specifications of Different Types of Recombinant Protein Drug

    • Figure Development Trends of Different Types

    • Table Commercial Products Types of Major Vendors

    • Figure Competitive Landscape Analysis of Different Types

    • Table Consumption of Recombinant Protein Drug by Different Types from 2014 to 2026

    • Table Consumption Share of Recombinant Protein Drug by Different Types from 2014 to 2026

    • Figure Market Size and Growth Rate of Recombinant Insulin

    • Figure Market Size and Growth Rate of Recombinant Human Interferon (rhIFN)

    • Figure Market Size and Growth Rate of Recombinant Human Erythropoietin (rhEPO)

    • Figure Market Size and Growth Rate of Recombinant Human Granulocyte Colony-stimulating Factor (rhG-CSF)

    • Figure Market Size and Growth Rate of Recombinant Human Growth Hormone (rhGH)

    • Figure Market Size and Growth Rate of Recombinant Human Follicle-stimulating Hormone (rh

    • Table Downstream Client Analysis by End-Users

    • Figure Competitive Landscape Analysis of Different End-Users

    • Table Market Potential Analysis of Different End-Users

    • Table Consumption of Recombinant Protein Drug by Different End-Users from 2014 to 2026

    • Table Consumption Share of Recombinant Protein Drug by Different End-Users from 2014 to 2026

    • Figure Market Size and Growth Rate of Hospital use

    • Figure Market Size and Growth Rate of Clinic use

    • Figure Market Size and Growth Rate of Household

    • Table Global Recombinant Protein Drug Production by Major Regions

    • Table Global Recombinant Protein Drug Production Share by Major Regions

    • Figure Global Recombinant Protein Drug Production Share by Major Regions in 2014

    • Figure Global Recombinant Protein Drug Production Share by Major Regions in 2018

    • Figure Global Recombinant Protein Drug Production Share by Major Regions in 2026

    • Table Global Recombinant Protein Drug Consumption by Major Regions

    • Table Global Recombinant Protein Drug Consumption Share by Major Regions

    • Figure Global Recombinant Protein Drug Consumption Share by Major Regions in 2014

    • Figure Global Recombinant Protein Drug Consumption Share by Major Regions in 2018

    • Figure Global Recombinant Protein Drug Consumption Share by Major Regions in 2026

    • Table North America Recombinant Protein Drug Production, Import, Consumption and Export Analysis

    • Table Europe Recombinant Protein Drug Production, Import, Consumption and Export Analysis

    • Table Asia Pacific Recombinant Protein Drug Production, Import, Consumption and Export Analysis

    • Table Latin America, Middle East & Africa Recombinant Protein Drug Production, Import, Consumption and Export Analysis

    • Table Top 5 Export Countries' Export Value Analysis in Recombinant Protein Drug market from 2014 to 2019

    • Table Top 5 Export Countries' Export Volume Analysis in Recombinant Protein Drug market from 2014 to 2019

    • Table Top 5 Import Countries' Import Value Analysis in Recombinant Protein Drug market from 2014 to 2019

    • Table Top 5 Import Countries' Import Volume Analysis in Recombinant Protein Drug market from 2014 to 2019

    • Figure Emerging Top 3 Export Countries Analysis

    • Figure Emerging Top 3 Import Countries Analysis

    • Table North America Recombinant Protein Drug Consumption by Types from 2014 to 2026

    • Table North America Recombinant Protein Drug Consumption Share by Types from 2014 to 2026

    • Figure North America Recombinant Protein Drug Consumption Share by Types in 2014

    • Figure North America Recombinant Protein Drug Consumption Share by Types in 2018

    • Figure North America Recombinant Protein Drug Consumption Share by Types in 2026

    • Table North America Recombinant Protein Drug Consumption by End-Users from 2014 to 2026

    • Table North America Recombinant Protein Drug Consumption Share by End-Users from 2014 to 2026

    • Figure North America Recombinant Protein Drug Consumption Share by End-Users in 2014

    • Figure North America Recombinant Protein Drug Consumption Share by End-Users in 2018

    • Figure North America Recombinant Protein Drug Consumption Share by End-Users in 2026

    • Table North America Recombinant Protein Drug Consumption by Major Countries from 2014 to 2026

    • Table North America Recombinant Protein Drug Consumption Share by Major Countries from 2014 to 2026

    • Figure North America Recombinant Protein Drug Consumption Share by Major Countries in 2014

    • Figure North America Recombinant Protein Drug Consumption Share by Major Countries in 2018

    • Figure North America Recombinant Protein Drug Consumption Share by Major Countries in 2026

    • Figure United States Recombinant Protein Drug Market Volume and Growth Rate from 2014 to 2026

    • Figure Canada Recombinant Protein Drug Market Volume and Growth Rate from 2014 to 2026

    • Figure Mexico Recombinant Protein Drug Market Volume and Growth Rate from 2014 to 2026

    • Table Europe Recombinant Protein Drug Consumption by Types from 2014 to 2026

    • Table Europe Recombinant Protein Drug Consumption Share by Types from 2014 to 2026

    • Figure Europe Recombinant Protein Drug Consumption Share by Types in 2014

    • Figure Europe Recombinant Protein Drug Consumption Share by Types in 2018

    • Figure Europe Recombinant Protein Drug Consumption Share by Types in 2026

    • Table Europe Recombinant Protein Drug Consumption by End-Users from 2014 to 2026

    • Table Europe Recombinant Protein Drug Consumption Share by End-Users from 2014 to 2026

    • Figure Europe Recombinant Protein Drug Consumption Share by End-Users in 2014

    • Figure Europe Recombinant Protein Drug Consumption Share by End-Users in 2018

    • Figure Europe Recombinant Protein Drug Consumption Share by End-Users in 2026

    • Table Europe Recombinant Protein Drug Consumption by Major Countries from 2014 to 2026

    • Table Europe Recombinant Protein Drug Consumption Share by Major Countries from 2014 to 2026

    • Figure Europe Recombinant Protein Drug Consumption Share by Major Countries in 2014

    • Figure Europe Recombinant Protein Drug Consumption Share by Major Countries in 2018

    • Figure Europe Recombinant Protein Drug Consumption Share by Major Countries in 2026

    • Figure Germany Recombinant Protein Drug Market Volume and Growth Rate from 2014 to 2026

    • Figure UK Recombinant Protein Drug Market Volume and Growth Rate from 2014 to 2026

    • Figure France Recombinant Protein Drug Market Volume and Growth Rate from 2014 to 2026

    • Figure Italy Recombinant Protein Drug Market Volume and Growth Rate from 2014 to 2026

    • Figure Nordic Countries Recombinant Protein Drug Market Volume and Growth Rate from 2014 to 2026

    • Figure Belgium Recombinant Protein Drug Market Volume and Growth Rate from 2014 to 2026

    • Figure Poland Recombinant Protein Drug Market Volume and Growth Rate from 2014 to 2026

    • Figure Russia Recombinant Protein Drug Market Volume and Growth Rate from 2014 to 2026

    • Figure Turkey Recombinant Protein Drug Market Volume and Growth Rate from 2014 to 2026

    • Table Asia Pacific Recombinant Protein Drug Consumption by Types from 2014 to 2026

    • Table Asia Pacific Recombinant Protein Drug Consumption Share by Types from 2014 to 2026

    • Figure Asia Pacific Recombinant Protein Drug Consumption Share by Types in 2014

    • Figure Asia Pacific Recombinant Protein Drug Consumption Share by Types in 2018

    • Figure Asia Pacific Recombinant Protein Drug Consumption Share by Types in 2026

    • Table Asia Pacific Recombinant Protein Drug Consumption by End-Users from 2014 to 2026

    • Table Asia Pacific Recombinant Protein Drug Consumption Share by End-Users from 2014 to 2026

    • Figure Asia Pacific Recombinant Protein Drug Consumption Share by End-Users in 2014

    • Figure Asia Pacific Recombinant Protein Drug Consumption Share by End-Users in 2018

    • Figure Asia Pacific Recombinant Protein Drug Consumption Share by End-Users in 2026

    • Table Asia Pacific Recombinant Protein Drug Consumption by Major Countries from 2014 to 2026

    • Table Asia Pacific Recombinant Protein Drug Consumption Share by Major Countries from 2014 to 2026

    • Figure Asia Pacific Recombinant Protein Drug Consumption Share by Major Countries in 2014

    • Figure Asia Pacific Recombinant Protein Drug Consumption Share by Major Countries in 2018

    • Figure Asia Pacific Recombinant Protein Drug Consumption Share by Major Countries in 2026

    • Figure China Recombinant Protein Drug Market Volume and Growth Rate from 2014 to 2026

    • Figure Japan Recombinant Protein Drug Market Volume and Growth Rate from 2014 to 2026

    • Figure Australia and New ZealandRecombinant Protein Drug Market Volume and Growth Rate from 2014 to 2026

    • Figure India Recombinant Protein Drug Market Volume and Growth Rate from 2014 to 2026

    • Figure ASEAN Countries Recombinant Protein Drug Market Volume and Growth Rate from 2014 to 2026

    • Figure South Korea Recombinant Protein Drug Market Volume and Growth Rate from 2014 to 2026

    • Table Latin America, Middle East & Africa Recombinant Protein Drug Consumption by Types from 2014 to 2026

    • Table Latin America, Middle East & Africa Recombinant Protein Drug Consumption Share by Types from 2014 to 2026

    • Figure Latin America, Middle East & Africa Recombinant Protein Drug Consumption Share by Types in 2014

    • Figure Latin America, Middle East & Africa Recombinant Protein Drug Consumption Share by Types in 2018

    • Figure Latin America, Middle East & Africa Recombinant Protein Drug Consumption Share by Types in 2026

    • Table Latin America, Middle East & Africa Recombinant Protein Drug Consumption by End-Users from 2014 to 2026

    • Table Latin America, Middle East & Africa Recombinant Protein Drug Consumption Share by End-Users from 2014 to 2026

    • Figure Latin America, Middle East & Africa Recombinant Protein Drug Consumption Share by End-Users in 2014

    • Figure Latin America, Middle East & Africa Recombinant Protein Drug Consumption Share by End-Users in 2018

    • Figure Latin America, Middle East & Africa Recombinant Protein Drug Consumption Share by End-Users in 2026

    • Table Latin America, Middle East & Africa Recombinant Protein Drug Consumption by Major Countries from 2014 to 2026

    • Table Latin America, Middle East & Africa Recombinant Protein Drug Consumption Share by Major Countries from 2014 to 2026

    • Figure Latin America, Middle East & Africa Recombinant Protein Drug Consumption Share by Major Countries in 2014

    • Figure Latin America, Middle East & Africa Recombinant Protein Drug Consumption Share by Major Countries in 2018

    • Figure Latin America, Middle East & Africa Recombinant Protein Drug Consumption Share by Major Countries in 2026

    • Figure GCC Countries Recombinant Protein Drug Market Volume and Growth Rate from 2014 to 2026

    • Figure Brazil Recombinant Protein Drug Market Volume and Growth Rate from 2014 to 2026

    • Figure Nigeria Recombinant Protein Drug Market Volume and Growth Rate from 2014 to 2026

    • Figure South Africa Recombinant Protein Drug Market Volume and Growth Rate from 2014 to 2026

    • Figure Argentina Recombinant Protein Drug Market Volume and Growth Rate from 2014 to 2026

    • Table Company Profile and Development Status of NCPC

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of NCPC

    • Figure Sales and Growth Rate Analysis of NCPC

    • Figure Revenue and Market Share Analysis of NCPC

    • Table Product and Service Introduction of NCPC

    • Table Company Profile and Development Status of Pharmingen

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Pharmingen

    • Figure Sales and Growth Rate Analysis of Pharmingen

    • Figure Revenue and Market Share Analysis of Pharmingen

    • Table Product and Service Introduction of Pharmingen

    • Table Company Profile and Development Status of Merck Serono

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Merck Serono

    • Figure Sales and Growth Rate Analysis of Merck Serono

    • Figure Revenue and Market Share Analysis of Merck Serono

    • Table Product and Service Introduction of Merck Serono

    • Table Company Profile and Development Status of GenSci

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of GenSci

    • Figure Sales and Growth Rate Analysis of GenSci

    • Figure Revenue and Market Share Analysis of GenSci

    • Table Product and Service Introduction of GenSci

    • Table Company Profile and Development Status of Kyowa Hakko Kirin

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Kyowa Hakko Kirin

    • Figure Sales and Growth Rate Analysis of Kyowa Hakko Kirin

    • Figure Revenue and Market Share Analysis of Kyowa Hakko Kirin

    • Table Product and Service Introduction of Kyowa Hakko Kirin

    • Table Company Profile and Development Status of Anhui Anke Biotechnology

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Anhui Anke Biotechnology

    • Figure Sales and Growth Rate Analysis of Anhui Anke Biotechnology

    • Figure Revenue and Market Share Analysis of Anhui Anke Biotechnology

    • Table Product and Service Introduction of Anhui Anke Biotechnology

    • Table Company Profile and Development Status of Novo Nordisk

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Novo Nordisk

    • Figure Sales and Growth Rate Analysis of Novo Nordisk

    • Figure Revenue and Market Share Analysis of Novo Nordisk

    • Table Product and Service Introduction of Novo Nordisk

    • Table Company Profile and Development Status of Sanofi

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Sanofi

    • Figure Sales and Growth Rate Analysis of Sanofi

    • Figure Revenue and Market Share Analysis of Sanofi

    • Table Product and Service Introduction of Sanofi

    • Table Company Profile and Development Status of Abcam

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Abcam

    • Figure Sales and Growth Rate Analysis of Abcam

    • Figure Revenue and Market Share Analysis of Abcam

    • Table Product and Service Introduction of Abcam

    • Table Company Profile and Development Status of Eli Lilly

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Eli Lilly

    • Figure Sales and Growth Rate Analysis of Eli Lilly

    • Figure Revenue and Market Share Analysis of Eli Lilly

    • Table Product and Service Introduction of Eli Lilly

    • Table Company Profile and Development Status of SL PHARM

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of SL PHARM

    • Figure Sales and Growth Rate Analysis of SL PHARM

    • Figure Revenue and Market Share Analysis of SL PHARM

    • Table Product and Service Introduction of SL PHARM

    • Table Company Profile and Development Status of Changchun High & New Technology Industry

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Changchun High & New Technology Industry

    • Figure Sales and Growth Rate Analysis of Changchun High & New Technology Industry

    • Figure Revenue and Market Share Analysis of Changchun High & New Technology Industry

    • Table Product and Service Introduction of Changchun High & New Technology Industry

    • Table Company Profile and Development Status of Amgen

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Amgen

    • Figure Sales and Growth Rate Analysis of Amgen

    • Figure Revenue and Market Share Analysis of Amgen

    • Table Product and Service Introduction of Amgen

    • Table Company Profile and Development Status of Heng Rui

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Heng Rui

    • Figure Sales and Growth Rate Analysis of Heng Rui

    • Figure Revenue and Market Share Analysis of Heng Rui

    • Table Product and Service Introduction of Heng Rui

    • Table Company Profile and Development Status of Ortho Biotech

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Ortho Biotech

    • Figure Sales and Growth Rate Analysis of Ortho Biotech

    • Figure Revenue and Market Share Analysis of Ortho Biotech

    • Table Product and Service Introduction of Ortho Biotech

    • Table Company Profile and Development Status of Shenzhen Neptunus Interlong Bio-Technique

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Shenzhen Neptunus Interlong Bio-Technique

    • Figure Sales and Growth Rate Analysis of Shenzhen Neptunus Interlong Bio-Technique

    • Figure Revenue and Market Share Analysis of Shenzhen Neptunus Interlong Bio-Technique

    • Table Product and Service Introduction of Shenzhen Neptunus Interlong Bio-Technique

    • Table Company Profile and Development Status of Livzon Pharm

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Livzon Pharm

    • Figure Sales and Growth Rate Analysis of Livzon Pharm

    • Figure Revenue and Market Share Analysis of Livzon Pharm

    • Table Product and Service Introduction of Livzon Pharm

    • Table Company Profile and Development Status of Roche

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Roche

    • Figure Sales and Growth Rate Analysis of Roche

    • Figure Revenue and Market Share Analysis of Roche

    • Table Product and Service Introduction of Roche


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US